Cargando…

Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease

Detalles Bibliográficos
Autores principales:	Núñez, Alexa, Belmonte, Irene, Miranda, Elena, Barrecheguren, Miriam, Farago, Georgina, Loeb, Eduardo, Pons, Mònica, Rodríguez-Frías, Francisco, Gabriel-Medina, Pablo, Rodríguez, Esther, Genescà, Joan, Miravitlles, Marc, Esquinas, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559341/ https://www.ncbi.nlm.nih.gov/pubmed/34719403 http://dx.doi.org/10.1186/s12931-021-01874-x

Ejemplares similares

Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
por: Núñez, Alexa, et al.
Publicado: (2021)

New variants of alpha-1-antitrypsin: structural simulations and clinical expression
por: Gonzalez, Angel, et al.
Publicado: (2022)

Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin Deficiency
por: Pons, Mònica, et al.
Publicado: (2021)

Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory
por: Belmonte, Irene, et al.
Publicado: (2020)

Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach
por: Belmonte, Irene, et al.
Publicado: (2016)

Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency
por: Esquinas, Cristina, et al.
Publicado: (2017)

Practice and knowledge about diagnosis and treatment of alpha-1 antitrypsin deficiency in Spain and Portugal
por: Esquinas, Cristina, et al.
Publicado: (2016)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)
por: Esquinas, Cristina, et al.
Publicado: (2018)

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
por: Greulich, Timm, et al.
Publicado: (2018)

Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
por: Núñez, Alexa, et al.
Publicado: (2018)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
por: Miravitlles, Marc, et al.
Publicado: (2022)

Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2018)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
por: Torres-Durán, María, et al.
Publicado: (2018)

Correction: Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2019)

Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
por: Miravitlles, Marc, et al.
Publicado: (2023)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2020)

Demographic and clinical characteristics of patients with α(1)-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
por: Torres-Durán, María, et al.
Publicado: (2022)

Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update
por: Blanco, Ignacio, et al.
Publicado: (2017)

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide
por: Blanco, Ignacio, et al.
Publicado: (2017)

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
por: Torres-Durán, María, et al.
Publicado: (2023)

Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
por: Stockley, Robert A, et al.
Publicado: (2013)

Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency
por: Lara, Beatriz, et al.
Publicado: (2007)

Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2015)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
por: Stockley, Robert A., et al.
Publicado: (2023)

Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
por: Parr, David G., et al.
Publicado: (2022)

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil
por: Jardim, José R, et al.
Publicado: (2021)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
por: Rahaghi, Franck F., et al.
Publicado: (2017)

COPD heterogeneity: implications for management
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease
por: Nuñez, Alexa, et al.
Publicado: (2020)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)

Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain
por: Barrecheguren, Miriam, et al.
Publicado: (2022)

Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide
por: Martinez-González, Cristina, et al.
Publicado: (2021)

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?
por: Rodríguez-García, Carlota, et al.
Publicado: (2023)

Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis
por: Barjaktarevic, Igor, et al.
Publicado: (2021)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
por: Calle Rubio, Myriam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2cl2c79i6u8e18oehtfgrm5f0v